MediSwipe, Inc. Announces Expansion of Corporate Headquarters in Colorado to Include Oncology Clinical Trial Partner and Testing Facility
April 11, 2014 - LOS ANGELES, CA
LOS ANGELES, CA--(Marketwired - April 11, 2014) - MediSwipe, Inc. (www.MediSwipe.com) (OTCQB: MWIP), a fully reporting company on the OTCQB, a leader in Compassionate Care Technology and indoor/outdoor agricultural solutions for the medicinal marijuana industry, today announced that the Company has expanded its corporate presence in Denver, Colorado to now include 7,500 sq. ft. of office space for a multi-year term. The new offices located within the Cherry Creek subdivision and office complex will include sharing the space with an established, Colorado based oncology clinical trial and drug testing company and facility presently doing cancer research and testing for established pharmaceutical companies seeking FDA approval for new drugs.
"We have obviously begun to make a substantial commitment and investment within the state of Colorado with our previously announced agreements for ownership interests of approximately one-hundred and sixty acres zoned for agricultural use and the build out of our two managed green house facilities. It was quite opportunistic for us to find this amount of executive office space cost effectively which will allow us to expand our onsite management and sales team beginning this month. At the same time, we have found a potential synergistic partner within the oncology and pharmaceutical testing side that could provide a value added service to our clients and patients," stated B. Michael Friedman, CEO of MediSwipe.
"We believe the testing facility could create an extremely valuable vertical service by giving our tenants from the green house farms the ability to test harvests providing insightful data on THC and CBD levels of medicine once proper licensing by the state is granted to our partners as a private, licensed Colorado based testing facility. MediSwipe could provide the ability to store all results and analytical data on our cloud based system on behalf of the testing facility, tracking the quality and consistency of medicine and provide documented data of patient progress from multiple strains both THC and CBD specific on behalf of the state licensed facility once approved," added Friedman.
About MediSwipe, Inc.
MediSwipe, Inc. (www.MediSwipe.com), the first fully reporting Company and pioneer within the medicinal marijuana space, provides innovative patient and agricultural solutions seeks to be the leader in Compassionate Care Technology for the medicinal marijuana industry. MediSwipe provides real estate management and health and wellness product lines including beverages, vaporizers and accessories. MediSwipe does not directly grow, harvest, or distribute or sell cannabis or any substances that violate United States law or the Controlled Substances Act, nor does it intend to do so in the future.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of MediSwipe, Inc. to be materially different from the statements made herein.